HRS 2020: New Trial Data Support Medtronic’s Micra Pacemaker
Executive Summary
The Micra CED study showed a lower rate of complications with the Micra leadless pacemaker than transvenous single-chamber pacemakers.
You may also be interested in...
Minute Insight: Medtronic Counters Abbott With New Micra Leadless Pacemakers
About a month after it approved Abbott’s Aveir VR leadless pacemaker, the FDA approved two new models of Medtronic’s Micra leadless pacemaker.
FDA Warns Of Severe Risks Associated With Medtronic Leadless Pacemakers
The US Food and Drug Administration has issued a warning to clinicians of the heightened risk for adverse events, including death, from potential cardiac perforation during implantation of Medtronic’s Micra Transcatheter Pacing System (TPS).
Cardiovascular Catch-Up: Abbott, Medtronic, Boston Scientific Stay Hot During Summer
June, July and August brought a number of important new approvals and trial announcements from the major cardiac device companies. Here are some of the highlights you might have missed during the summer.